AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · New York

A03581

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

Status

Did not pass; died when the session ended

2024 Session

IntroducedFeb 3, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Patrick Burke (Democrat)
Type: Clinical Research
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: nysenate.gov

Legislative history

January 3, 2024
Referred
January 3, 2024
Referred
February 3, 2023
Referred
February 3, 2023
Introduced

Loading bill…